Cardioversion or rate control for atrial fibrillation: balancing risks and benefits.
Ellenbogen
K A
KA
Clinical electrophysiology and pacing program, Medical College of Virginia, USA.
Tchou
P J
PJ
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D002561:Cerebrovascular Disorders / Q000209:etiology; D004554:Electric Countershock; D006801:Humans; D012307:Risk Factors
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants